Cardiff Oncology, Inc.
CRDF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,258 | -$13,943 | -$13,434 | -$11,787 |
| Dep. & Amort. | $494 | $229 | $228 | $96 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,384 | $0 | $1,365 | $1,204 |
| Change in WC | -$1,202 | $4,004 | -$816 | $378 |
| Other Non-Cash | -$252 | $1,382 | -$137 | -$158 |
| Operating Cash Flow | -$10,834 | -$8,328 | -$12,794 | -$10,267 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$18 | -$26 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$9,341 | -$19,985 | -$34,910 | $0 |
| Inv. Sales/Matur. | $19,519 | $15,028 | $21,228 | $4,511 |
| Other Inv. Act. | $0 | $0 | -$902 | $0 |
| Investing Cash Flow | $10,160 | -$4,983 | -$14,584 | $4,511 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $3 | $44,175 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $25 | $0 | $0 | $13 |
| Financing Cash Flow | $25 | $0 | $3 | $44,188 |
| Forex Effect | $0 | -$0 | $0 | $0 |
| Net Chg. in Cash | -$649 | -$13,311 | -$27,375 | $38,432 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10,784 | $24,095 | $51,470 | $13,038 |
| End Cash | $10,135 | $10,784 | $24,095 | $51,470 |
| Free Cash Flow | -$10,852 | -$8,354 | -$12,794 | -$10,267 |